Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

Pathology Show Comments PDF Print E-mail
  

  • 90 percent of lesions are TCC, 5-9 percent of lesions squamous cell and 1-2 percent of lesions adenocarcinoma. Primary TCC with metaplastic elements is not uncommon. Cytologic grade adds some independent prognostic information by interpretation on a 1-3 scale is less uniform. Tumor stage is the predominant factor in prognostic outcome.
  • Epithelial dysplasia. Dysplasia exhibits irregular urothelial and nuclear changes in a gradation toward carcinoma. High-grade dysplasia is difficult to distinguish from CIS. This is distinct from atypia, which is defined as an in­crease in cell layer number without changes in tissue structure or nuclear appearance.
  • Carcinoma in situ. Similar to high grade dysplasia, yet lacks polarity and cell adhesion. Probable progenitor of muscle invasive disease.
  • Superficial disease Papillary or nodular lesions confined to the mucosa [Ta] constitute true superficial disease. Lesions invading the lamina propria [T1] have a significantly higher chance of recurrence and progression [30-40 percent]. They require aggressive treatment and close observation.
  • Muscle invasive disease. True involvement of the detrusor which can appear nodular or tentacular. Generally all of high cytologic grade.
  • Squamous cell. Secondary to chronic irritation. Stone disease and chronic cathers as well as schistosomiasis infection.
  • Adenocarcinoma. Rare lesions. Likely urarchal origin when at bladder dome. Must rule out metastatic deposit from another primary site such as breast or colon.
  • Sarcoma. Rare in adults. Embryonal rhabdomyosarcoma seen in infants and young children.
  • Small cell carcinoma. Rare lesions with neuroendocrine features. Generally very aggressive clinical course.

Reader Comments
DO
Written by This email address is being protected from spam bots, you need Javascript enabled to view it on 2009-11-20 10:45:50
Good subject.
MD
Written by This email address is being protected from spam bots, you need Javascript enabled to view it on 2007-11-15 13:39:39
Nice review

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 7
PoorBest


 
Visitor Ratings:
Healthcare Professionals:
5 (7 votes)

Patients:
5 (1 votes)

No Affiliation:
4 (1 votes)


Bookmark and Share

Member's Section

Login

Sign Up

Quick Search

Meet the Expert


All Experts


Featured Conference

Working with Industry

Case Studies
Sponsorship Opportunities

Bladder Cancer
Sponsored By